Morone, G., Angelis, L. D., Cinnera, A. M., Carbonetti, R., Bisirri, A., Ciancarelli, I., Iosa, M., Negrini, S., Kiekens, C., and Negrini, F., Artificial intelligence in clinical medicine: A state-of-the-art overview of systematic reviews with methodological recommendations for improved reporting. Front. Digit. Health. 7:1550731, 2025. https://doi.org/10.3389/fdgth.2025.1550731

Ouanes, K., and Farhah, N., Effectiveness of artificial intelligence (ai) in clinical decision support systems and care delivery. J. Med. Syst. 48:74, 2024. https://doi.org/10.1007/s10916-024-02098-4

Topol, E. J., High-performance medicine: The convergence of human and artificial intelligence. Nat. Med. 25:44–56, 2019. https://doi.org/10.1038/s41591-018-0300-7

Moulaei, K., Yadegari, A., Baharestani, M., Farzanbakhsh, S., Sabet, B., and Reza Afrash, M., Generative artificial intelligence in healthcare: A scoping review on benefits, challenges and applications. Int. J. Med. Inform. 188:105474, 2024. https://doi.org/10.1016/j.ijmedinf.2024.105474

McGenity, C., Clarke, E. L., Jennings, C., et al., Artificial intelligence in digital pathology: A systematic review and meta-analysis of diagnostic test accuracy. npj Digit. Med. 7:114, 2024. https://doi.org/10.1038/s41746-024-01106-8

Takita, H., Kabata, D., Walston, S. L., et al., A systematic review and meta-analysis of diagnostic performance comparison between generative ai and physicians. npj Digit. Med. 8:175, 2025. https://doi.org/10.1038/s41746-025-01543-z

Lococo, F., Ghaly, G., Chiappetta, M., Flamini, S., Evangelista, J., Bria, E., Stefani, A., Vita, E., Martino, A., Boldrini, L., Sassorossi, C., Campanella, A., Margaritora, S., and Mohammed, A., Implementation of artificial intelligence in personalized prognostic assessment of lung cancer: A narrative review. Cancers 16(10), 2024. https://doi.org/10.3390/cancers16101832

Alum, E. U., and Ugwu, O. P. C., Artificial intelligence in personalized medicine: Transforming diagnosis and treatment. Discov. Appl. Sci. 7:193, 2025. https://doi.org/10.1007/s42452-025-06625-x

Lin, S.-C., Nateqi, J., Weingartner-Ortner, R., Gruarin, S., Marling, H., Pilgram, V., Lagler, F. B., Aigner, E., and Martin, A. G., An artificial intelligence-based approach for identifying rare disease patients using retrospective electronic health records applied for pompe disease. Front. Neurol. 14:1108222, 2023. https://doi.org/10.3389/fneur.2023.1108222

Visibelli, A., Roncaglia, B., Spiga, O., and Santucci, A., The impact of artificial intelligence in the odyssey of rare diseases. Biomedicines 11(3), 2023. https://doi.org/10.3390/biomedicines11030887

Roman-Naranjo, P., Parra-Perez, A. M., and Lopez-Escamez, J. A., A systematic review on machine learning approaches in the diagnosis and prognosis of rare genetic diseases. J. Biomed. Inf. 143:104429, 2023. https://doi.org/10.1016/j.jbi.2023.104429

Longato, E., Tavazzi, E., Chió, A., Mora, G., Sparacino, G., and Camillo, B. D., Dealing with data scarcity in rare diseases: Dynamic bayesian networks and transfer learning to develop prognostic models of amyotrophic lateral sclerosis. In: Juarez, J. M., Marcos, M., Stiglic, G., and Tucker, A. (Eds.), Artificial Intelligence in Medicine. AIME 2023. Lecture Notes in Computer Science. Vol. 13897. Portorož, Slovenia: Springer, 2023. https://doi.org/10.1007/978-3-031-34344-5_18

Alganmi, N., A comprehensive review of the impact of machine learning and omics on rare neurological diseases. BioMedInformatics 4(2):1329–1347, 2024. https://doi.org/10.3390/biomedinformatics4020073

Brasil, S., Neves, C. J., Rijoff, T., Falcão, M., Valadão, G., Videira, P. A., and Reis Ferreira, V., Artificial intelligence in epigenetic studies: Shedding light on rare diseases. Front. Mol. Biosci. 8:648012, 2021. https://doi.org/10.3389/fmolb.2021.648012

Huang, E.-J., Wu, M.-H., Wang, T.-J., Huang, T.-J., Li, Y.-R., and Lee, C.-Y., Myasthenia gravis: Novel findings and perspectives on traditional to regenerative therapeutic interventions. Aging Dis. 14(4):1070–1092, 2023. https://doi.org/10.14336/AD.2022.1215

Attarian, S., New treatment strategies in myasthenia gravis. Rev. Neurol. 180(9):971–981, 2024. https://doi.org/10.1016/j.neurol.2024.09.006. History and novelties in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes

Garbey, M., Lesport, Q., Girma, H., Öztosun, G., Abu-Rub, M., Guidon, A. C., Juel, V., Nowak, R. J., Soliven, B., Aban, I., and Kaminski, H. J., Application of digital tools and artificial intelligence in the myasthenia gravis core examination. Front. Neurol. Volume 15 - 2024, 2024. https://doi.org/10.3389/fneur.2024.1474884

Severcan, F., Ozyurt, I., Dogan, A., Severcan, M., Gurbanov, R., Kucukcankurt, F., Elibol, B., Tiftikcioglu, I., Gursoy, E., Yangin, M. N., and Zorlu, Y., Decoding myasthenia gravis: Advanced diagnosis with infrared spectroscopy and machine learning. Sci. Rep. 14(1):19316, 2024. https://doi.org/10.1038/s41598-024-66501-3

Taha, M. A., and Morren, J. A., The role of artificial intelligence in electrodiagnostic and neuromuscular medicine: Current state and future directions. Muscle & Nerve 69(3):260–272, 2024. https://doi.org/10.1002/mus.28023. https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.28023

Kolbinger, F. R., Veldhuizen, G. P., Zhu, J., et al., Reporting guidelines in medical artificial intelligence: A systematic review and meta-analysis. Commun. Med. 4:71, 2024. https://doi.org/10.1038/s43856-024-00492-0

Collins, G. S., Dhiman, P., Andaur Navarro, C. L., Ma, J., Hooft, L., Reitsma, J. B., Logullo, P., Beam, A. L., Peng, L., Van Calster, B., Smeden, M., Riley, R. D., and Moons, K. G., Protocol for development of a reporting guideline (tripod-ai) and risk of bias tool (probast-ai) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open 11(7), 2021. https://doi.org/10.1136/bmjopen-2020-048008. https://bmjopen.bmj.com/content/11/7/e048008.full.pdf

Collins, G. S., Moons, K. G. M., Dhiman, P., Riley, R. D., Beam, A. L., Van Calster, B., Ghassemi, M., Liu, X., Reitsma, J. B., Smeden, M., Boulesteix, A.-L., Camaradou, J. C., Celi, L. A., Denaxas, S., Denniston, A. K., Glocker, B., Golub, R. M., Harvey, H., Heinze, G., Hoffman, M. M., Kengne, A. P., Lam, E., Lee, N., Loder, E. W., Maier-Hein, L., Mateen, B. A., McCradden, M. D., Oakden-Rayner, L., Ordish, J., Parnell, R., Rose, S., Singh, K., Wynants, L., and Logullo, P., Tripod+ai statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 385, 2024. https://doi.org/10.1136/bmj-2023-078378. https://www.bmj.com/content/385/bmj-2023-078378.full.pdf

Liu, X., Rivera, S. C., Moher, D., Calvert, M. J., Denniston, A. K., Ashrafian, H., Beam, A. L., Chan, A.-W., Collins, G. S., Deeks, A. D. J., et al., Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: The consort-ai extension. Lancet Digit. Health 2(10):537–548, 2020.

Martindale, A. P. L., Llewellyn, C. D., Visser, R. O., et al., Concordance of randomised controlled trials for artificial intelligence interventions with the consort-ai reporting guidelines. Nat. Commun. 15:1619, 2024. https://doi.org/10.1038/s41467-024-45355-3

Sounderajah, V., Ashrafian, H., Golub, R. M., Shetty, S., De Fauw, J., Hooft, L., Moons, K., Collins, G., Moher, D., Bossuyt, P. M., Darzi, A., Karthikesalingam, A., Denniston, A. K., Mateen, B. A., Ting, D., Treanor, D., King, D., Greaves, F., Godwin, J., Pearson-Stuttard, J., Harling, L., McInnes, M., Rifai, N., Tomasev, N., Normahani, P., Whiting, P., Aggarwal, R., Vollmer, S., Markar, S. R., Panch, T., and Liu, X., Developing a reporting guideline for artificial intelligence-centred diagnostic test accuracy studies: The stard-ai protocol. BMJ Open 11(6), 2021. https://doi.org/10.1136/bmjopen-2020-047709. https://bmjopen.bmj.com/content/11/6/e047709.full.pdf

Rennie, O., Navigating the uncommon: Challenges in applying evidence-based medicine to rare diseases and the prospects of artificial intelligence solutions. Med. Health Care Philos. 27: 269–284, 2024. https://doi.org/10.1007/s11019-024-10206-x

Marconi, L., Pirovano, E., and Cabitza, F., CLARITY AI: A comprehensive checklist integrating established frameworks for enhanced research quality in medical AI studies. In: Calimeri, F., Dragoni, M., and Stella, F. (Eds.), Artificial Intelligence For Healthcare 2024: Proceedings of the 3rd AIxIA Workshop on Artificial Intelligence For Healthcare (HC@AIxIA 2024). CEUR Workshop Proceedings. Vol. 3880, pp. 1–14. Aachen, Germany: CEUR-WS.org, 2024. https://ceur-ws.org/Vol-3880/paper1.pdf

Ruiter, A. M., Wang, Z., Yin, Z., Naber, W. C., Simons, J., Blom, J. T., Gemert, J. C., Verschuuren, J. J. G. M., and Tannemaat, M. R., Assessing facial weakness in myasthenia gravis with facial recognition software and deep learning. Ann. Clin. Transl. Neurol. 10(8):1314–1325, 2023. https://doi.org/10.1002/acn3.51823. https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51823

Liu, Z., Zhu, Y., Yuan, Y., Yang, L., Wang, K., Wang, M., Yang, X., Wu, X., Tian, X., Zhang, R., et al., 3d densenet deep learning based preoperative computed tomography for detecting myasthenia gravis in patients with thymoma. Front. Oncol. 11:631964, 2021.

Qin, S., Ng, G., Lo, H., Li, Y., Cuneo, A., Preston, M., Ames, N., and Raiti, J., Application for measuring eyelid weakness in individuals with myasthenia gravis. Trials 39–42, 2021. https://doi.org/10.1109/GHTC53159.2021.9612418

Chang, C.-C., Yeh, J.-H., Chen, Y.-M., Jhou, M.-J., and Lu, C.-J., Clinical predictors of prolonged hospital stay in patients with myasthenia gravis: A study using machine learning algorithms. J. Clin. Med. 10(19), 2021. https://doi.org/10.3390/jcm10194393

Chang, C.-C., Yeh, J.-H., Chiu, H.-C., Chen, Y.-M., Jhou, M.-J., Liu, T.-C., and Lu, C.-J., Utilization of decision tree algorithms for supporting the prediction of intensive care unit admission of myasthenia gravis: A machine learning-based approach. J. Personal. Med. 12(1), 2022. https://doi.org/10.3390/jpm12010032

Steyaert, S., Lootus, M., Sarabu, C., Framroze, Z., Dickinson, H., Lewis, E., Steels, J.-C., and Rinaldo, F., A decentralized, prospective, observational study to collect real-world data from patients with myasthenia gravis using smartphones. Front. Neurol. Volume 14 - 2023, 2023. https://doi.org/10.3389/fneur.2023.1144183

Garbey, M., Joerger, G., Lesport, Q., Girma, H., McNett, S., Abu-Rub, M., and Kaminski, H., A digital telehealth system to compute myasthenia gravis core examination metrics: Exploratory cohort study. JMIR Neurotech. 2:43387, 2023. https://doi.org/10.2196/43387

Chang, C.-C., Yeh, J.-H., Chiu, H.-C., Liu, T.-C., Chen, Y.-M., Jhou, M.-J., and Lu, C.-J., Assessing the length of hospital stay for patients with myasthenia gravis based on the data mining mars approach. Front. Neurol. Volume 14 - 2023, 2023. https://doi.org/10.3389/fneur.2023.1283214

Lootus, M., Beatson, L., Atwood, L., Bourdais, T., Steyaert, S., Sarabu, C., Framroze, Z., Dickinson, H., Steels, J.-C., Lewis, E., Shah, N. R., and Rinaldo, F., Development and assessment of an artificial intelligence-based tool for ptosis measurement in adult myasthenia gravis patients using selfie video clips recorded on smartphones. Digit. Biomark. 7(1):63–73, 2023. https://doi.org/10.1159/000531224. https://karger.com/dib/article-pdf/7/1/63/4116702/000531224.pdf

Chang, C.-C., Liu, T.-C., Lu, C.-J., Chiu, H.-C., and Lin, W.-N., Machine learning strategy for identifying altered gut microbiomes for diagnostic screening in myasthenia gravis. Front. Microbiol. Volume 14 - 2023, 2023. https://doi.org/10.3389/fmicb.2023.1227300

Zhong, H., Ruan, Z., Yan, C., Lv, Z., Zheng, X., Goh, L.-Y., Xi, J., Song, J., Luo, L., Chu, L., Tan, S., Zhang, C., Bu, B., Da, Y., Duan, R., Yang, H., Luo, S., Chang, T., and, C. Z., Short-term outcome prediction for myasthenia gravis: An explainable machine learning model. Ther. Adv. Neurol. Disord. 16: 17562864231154976, 2023. https://doi.org/10.1177/17562864231154976

Wu, H., Zhang, Y., Chen, K., Jiang, Q., and Gao, L., A study on the construction of myasthenia gravis disease classification retrieval table and its intelligent classification model. In: Proceedings of the 2024 Guangdong-Hong Kong-Macao Greater Bay Area International Conference on Digital Economy and Artificial Intelligence. DEAI ’24, pp. 645–651. Association for Computing Machinery, New York, NY, USA (2024). https://doi.org/10.1145/3675417.3675524

Chang, C.-C., Liu, T.-C., Lu, C.-J., Chiu, H.-C., and Lin, W.-N., Explainable machine learning model for identifying key gut microbes and metabolites biomarkers associated with myasthenia gravis. Comput. Struct. Biotechnol. J. 23:1572–1583, 2024. https://doi.org/10.1016/j.csbj.2024.04.025

Liu, H., Liu, G., Guo, R., Li, S., and Chang, T., Identification of potential key genes for the comorbidity of myasthenia gravis with thymoma by integrated bioinformatics analysis and machine learning. Bioinform. Biol. Insights 18:11779322241281652, 2024. https://doi.org/10.1177/11779322241281652

Xu, Y., Li, Q., Pan, M., Jia, X., Wang, W., Guo, Q., and Luan, L., Interpretable machine learning models for predicting short-term prognosis in achr-ab+ generalized myasthenia gravis using clinical features and systemic inflammation index. Front. Neurol. Volume 15 - 2024, 2024. https://doi.org/10.3389/fneur.2024.1459555

Mahajan, P., Agarwal, T., Vekariya, D., Gupta, R., Malviya, A., Anandaraj, S. P., Jain, G., and Anand, D., Ontomg: A unique and ontological-based intelligent framework for early identification of myasthenia gravis (mg). Int. J. Inf. Technol. 16(6):3847–3853, 2024. https://doi.org/10.1007/s41870-024-01908-9

Kuo, C.-Y., Su, E. C.-Y., Yeh, H.-L., Yeh, J.-H., Chiu, H.-C., and Chung, C.-C., Predictive modeling and interpretative analysis of risks of instability in patients with myasthenia gravis requiring intensive care unit admission. Heliyon 10(24), 2024. https://doi.org/10.1016/j.heliyon.2024.e41084

Sha, Q., Zhang, Z., Li, H., Xu, Y., Wang, J., and Du, A., Serum metabolomic profile of myasthenia gravis and potential values as biomarkers in disease monitoring. Clin. Chim. Acta. 562:119873, 2024. https://doi.org/10.1016/j.cca.2024.119873

Li, Z., Miao, L., Ren, G., Wang, H., Shangguan, L., Zhao, H., and Li, X., Weighted gene coexpression network analysis and machine learning for the determination of tfh cell and b cell infiltrating biomarkers in thymoma-associated myasthenia gravis. Heliyon 10(14), 2024. https://doi.org/10.1016/j.heliyon.2024.e34364

Chang, C.-C., Liu, T.-C., Lu, C.-J., Chiu, H.-C., and Lin, W.-N., Explainable machine learning model for identifying key gut microbes and metabolites biomarkers associated with myasthenia gravis. Comput. Struct. Biotechnol. J. 23:1572–1583, 2024.

Brasil, S., Pascoal, C., Francisco, R., Reis Ferreira, V., A. Videira, P., and Valadão, G., Artificial intelligence (ai) in rare diseases: Is the future brighter? Genes 10(12), 2019. https://doi.org/10.3390/genes10120978

Conrad, K., Shoenfeld, Y., and Fritzler, M. J., Precision health: A pragmatic approach to understanding and addressing key factors in autoimmune diseases. Autoimmun. Rev. 19(5):102508, 2020. https://doi.org/10.1016/j.autrev.2020.102508

Faviez, C., Chen, X., Garcelon, N., et al., Diagnosis support systems for rare diseases: A scoping review. Orphanet J. Rare Dis. 15:94, 2020. https://doi.org/10.1186/s13023-020-01374-z

Marconi, L., and Cabitza, F., Show and tell: A critical review on robustness and uncertainty for a more responsible medical ai. Int. J. Med. Inform. 202:105970, 2025. https://doi.org/10.1016/j.ijmedinf.2025.105970